ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/24/2026
Back to search
Official data from USPTO
MESOBLAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MESOBLAST
ST13
US500000078596837Class
5, 42
Filing
78596837
Registration
3393731
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/25/2026
Trademark type
Word
Nice classes
5, 42
Filing date
03/29/2005
Registration date
03/04/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/16/2018
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
16
Owner location
Victoria, AU
Examiner
BUCHANAN WILL, NORA
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Mesoblast Limited
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; veterinary preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; biotechnology preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; medical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluidscultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantationmedical and surgical purposes but not including embryonic stem cells; human cells including stem cells but not embryonic stem cells; animal cells including stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatmentreconstruction and repair of tissue but not including preparations for embryonic stem cells
Class 42
Scientificmedical researchclinical researchpharmaceutical research and developmentadvisory and consultancy services in the field of T-cell productionT-cell immunotherapycell culture devicestissue engineering for cellular applications for humans and animalsstem cell bankingtissue bankingdrug discoveryvaccine screeningcell culture methodscell expansion technology including stem cell expansion technologycellular therapies including stem cell therapies and cellular transplants; none of the aforementioned services relating to embryonic stem cells
Publications
History of USPTO decisions and trademark events.
40 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/16/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/16/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/16/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/16/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
03/02/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/25/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/25/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/04/2017
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/12/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/11/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/11/2014
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
02/05/2014
ES8R
TEAS SECTION 8 RECEIVED
02/05/2014
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/04/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/28/2008
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/28/2008
DMCC
DATA MODIFICATION COMPLETED
01/28/2008
ALIE
ASSIGNED TO LIE
01/25/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2007
DOCK
ASSIGNED TO EXAMINER
11/14/2007
CNRT
NON-FINAL ACTION MAILED
11/05/2007
CNRT
NON-FINAL ACTION WRITTEN
11/05/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2007
CNSI
INQUIRY AS TO SUSPENSION MAILED
02/16/2007
CNSI
SUSPENSION INQUIRY WRITTEN
02/15/2007
CNSL
LETTER OF SUSPENSION MAILED
08/15/2006
CNSL
SUSPENSION LETTER WRITTEN
08/15/2006
DOCK
ASSIGNED TO EXAMINER
08/14/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/11/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2006
PAPER RECEIVED
04/24/2006
CNRT
NON-FINAL ACTION MAILED
10/31/2005
CNRT
NON-FINAL ACTION WRITTEN
10/28/2005
DOCK
ASSIGNED TO EXAMINER
10/25/2005
NWAP
NEW APPLICATION ENTERED
04/05/2005
Continuous trademark protection
Get notified about every new filing that threatens MESOBLAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.